SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
Long-Acting Therapy: What Observational Data Tell Us About the "Real World"
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
4 of
4
|
Long-Term CAB+RPV LA Effectiveness in Virologically Suppressed Individuals in the OPERA Cohort (ABSTRACT
674)
Michael Sension
CAN Community Health, Fort Lauderdale, FL, USA
Clinical Outcomes Among Virologically Suppressed Women Receiving CAB+RPV LA in the OPERA Cohort (ABSTRACT
676)
Jessica A. Altamirano
CAN Community Health, Fort Lauderdale, FL, USA
Long-Acting Cabotegravir and Rilpivirine in Older People With HIV in the GEPPO Cohort (ABSTRACT
677)
Andrea Calcagno
University of Turin, Turin, Italy
Long-Acting Cabotegravir/Rilpivirine in Real Life: Sex-Based Characteristics, PROs, and Effectiveness (ABSTRACT
678)
Ana González-Cordón
Hospital Clinic of Barcelona, Barcelona, Spain
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
4 of
4
|
